Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 1;176(5):e220142.
doi: 10.1001/jamapediatrics.2022.0142. Epub 2022 May 2.

Reporting of Participant Race and Ethnicity in Published US Pediatric Clinical Trials From 2011 to 2020

Chris A Rees  1   2 , Amanda M Stewart  3   4 , Sagar Mehta  1   2 , Elorm Avakame  5 , Jasmyne Jackson  4 , Jheanelle McKay  3   4 , Elyse N Portillo  6   7 , Kenneth A Michelson  3   4 , Christopher P Duggan  3   8   9 , Eric W Fleegler  3   4
Affiliations

Reporting of Participant Race and Ethnicity in Published US Pediatric Clinical Trials From 2011 to 2020

Chris A Rees et al. JAMA Pediatr. .

Abstract

Importance: Equitable representation of participants who are members of racial and ethnic minority groups in clinical trials enhances inclusivity in the scientific process and generalizability of results.

Objective: To assess participant race and ethnicity in pediatric clinical trials published from 2011 to 2020.

Design, setting, and participants: This cross-sectional study examined articles reporting pediatric clinical trials conducted in the US published in 5 leading general pediatric and 5 leading general medical journals from January 1, 2011, to December 31, 2020.

Main outcomes and measures: Reporting of participant race and ethnicity and comparison of enrolled participants vs US census populations of pediatric racial and ethnic groups in published clinical trials.

Results: The study included 612 articles reporting pediatric clinical trials during the study period, with 565 618 total participants (median per trial, 200 participants [IQR, 90-571 participants]). Of the 612 articles, 486 (79.4%) reported participant race and 338 (55.2%) reported participant ethnicity. From 2011 to 2020, relative rates of reporting of participant race increased by 7.9% per year (95% CI, 0.2%-16.3% per year) and reporting of ethnicity increased by 11.4% per year (95% CI, 4.8%-18.4% per year). Among articles reporting race and ethnicity, the method of assignment was not reported in 261 of 511 articles (51.1%) and 207 of 359 articles (57.7%), respectively. Black/African American children were enrolled proportionally more than the US population of Black/African American children (odds ratio [OR], 1.88; 95% CI, 1.87-1.89). Hispanic/Latino children were enrolled commensurately with the US population of Hispanic/Latino children (OR, 1.02; 95% CI, 1.01-1.03). American Indian/Alaska Native (OR, 0.82; 95% CI, 0.79-0.85), Asian (OR, 0.56; 95% CI, 0.55-0.57), and Native Hawaiian/Pacific Islander (OR, 0.66; 95% CI, 0.61-0.72) children were enrolled significantly less compared with the respective US populations of these groups. White children were enrolled less than expected (OR, 0.84; 95% CI, 0.84-0.85) but represented 188 156 (46.0%) of participants in trials reporting race or ethnicity.

Conclusions and relevance: This cross-sectional study revealed that the proportion of published pediatric clinical trials that reported participant race and ethnicity increased from 2011 to 2020, but participant race and ethnicity were still underreported. Disparities existed in pediatric clinical trial enrollment of American Indian/Alaska Native, Asian, and Native Hawaiian/Pacific Islander children. The greater representation of Black/African American children compared with the US population suggests inclusive research practices that could be extended to other historically disenfranchised racial and ethnic groups.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Duggan reported receiving royalties from PMPH USA and UpToDate, Inc, and income for editorial duties from the American Society for Nutrition outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Reporting of Participant Race and Ethnicity and the Trial Diversity Index in Pediatric Clinical Trials From 2011 to 2020
A, The n values shown are the number of trials. B, The n values shown are the number of participants.
Figure 2.
Figure 2.. Pediatric Clinical Trial Enrollment by State Among Trials Exclusively Conducted in a Single State
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hartling L, Scott-Findlay S, Johnson D, et al. ; Canadian Institutes for Health Research Team in Pediatric Emergency Medicine . Bridging the gap between clinical research and knowledge translation in pediatric emergency medicine. Acad Emerg Med. 2007;14(11):968-977. doi:10.1197/j.aem.2007.05.010 - DOI - PubMed
    1. Garg N, Round TP, Daker-White G, Bower P, Griffiths CJ. Attitudes to participating in a birth cohort study, views from a multiethnic population: a qualitative study using focus groups. Health Expect. 2017;20(1):146-158. doi:10.1111/hex.12445 - DOI - PMC - PubMed
    1. Leiter A, Diefenbach MA, Doucette J, Oh WK, Galsky MD. Clinical trial awareness: changes over time and sociodemographic disparities. Clin Trials. 2015;12(3):215-223. doi:10.1177/1740774515571917 - DOI - PMC - PubMed
    1. Amutah C, Greenidge K, Mante A, et al. . Misrepresenting race—the role of medical schools in propagating physician bias. N Engl J Med. 2021;384(9):872-878. doi:10.1056/NEJMms2025768 - DOI - PubMed
    1. Jones CP. Toward the science and practice of anti-racism: launching a national campaign against racism. Ethn Dis. 2018;28(suppl 1):231-234. doi:10.18865/ed.28.S1.231 - DOI - PMC - PubMed

Publication types